| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving a Preoperative Target HbA1c of < 69 mmol/mol in Elective Vascular and Orthopedic Surgery: A Retrospective Single Center Observational Study
|
Uppal, Celina
|
|
2019
|
10 |
5 |
p. 1959-1967
|
artikel
|
| 2 |
Achieving a Preoperative Target HbA1c of < 69 mmol/mol in Elective Vascular and Orthopedic Surgery: A Retrospective Single Center Observational Study
|
Uppal, Celina
|
|
|
10 |
5 |
p. 1959-1967
|
artikel
|
| 3 |
An Evaluation System of Fundus Photograph-Based Intelligent Diagnostic Technology for Diabetic Retinopathy and Applicability for Research
|
Yang, Wei-Hua
|
|
2019
|
10 |
5 |
p. 1811-1822
|
artikel
|
| 4 |
An Evaluation System of Fundus Photograph-Based Intelligent Diagnostic Technology for Diabetic Retinopathy and Applicability for Research
|
Yang, Wei-Hua
|
|
|
10 |
5 |
p. 1811-1822
|
artikel
|
| 5 |
Cardiorenal Protection: Potential of SGLT2 Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes
|
Nagahisa, Taichi
|
|
2019
|
10 |
5 |
p. 1733-1752
|
artikel
|
| 6 |
Cardiorenal Protection: Potential of SGLT2Inhibitors and GLP-1 Receptor Agonists in the Treatment of Type 2Diabetes
|
Nagahisa, Taichi
|
|
|
10 |
5 |
p. 1733-1752
|
artikel
|
| 7 |
Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review
|
Willis, Michael
|
|
2019
|
10 |
5 |
p. 1753-1769
|
artikel
|
| 8 |
Challenges and Opportunities Associated with Incorporating New Evidence of Drug-Mediated Cardioprotection in the Economic Modeling of Type 2 Diabetes: A Literature Review
|
Willis, Michael
|
|
|
10 |
5 |
p. 1753-1769
|
artikel
|
| 9 |
Cluster Analysis of Unhealthy Lifestyles among Elderly Adults with Prediabetes: A Cross-Sectional Study in Rural China
|
Wang, Xiaofen
|
|
2019
|
10 |
5 |
p. 1935-1948
|
artikel
|
| 10 |
Cluster Analysis of Unhealthy Lifestyles among Elderly Adults with Prediabetes: A Cross-Sectional Study in Rural China
|
Wang, Xiaofen
|
|
|
10 |
5 |
p. 1935-1948
|
artikel
|
| 11 |
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study
|
Noda, Tomoho
|
|
2019
|
10 |
5 |
p. 1835-1846
|
artikel
|
| 12 |
Concurrent Use of Teneligliptin and Canagliflozin Improves Glycemic Control with Beneficial Effects on Plasma Glucagon and Glucagon-Like Peptide-1: A Single-Arm Study
|
Noda, Tomoho
|
|
|
10 |
5 |
p. 1835-1846
|
artikel
|
| 13 |
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
|
Kalra, Sanjay
|
|
2019
|
10 |
5 |
p. 1645-1717
|
artikel
|
| 14 |
Consensus Recommendations on GLP-1 RA Use in the Management of Type 2 Diabetes Mellitus: South Asian Task Force
|
Kalra, Sanjay
|
|
|
10 |
5 |
p. 1645-1717
|
artikel
|
| 15 |
Correction to: A Practical Guide to Delivering Nutritional Advice to People with Diabetes
|
Dyson, Pamela A.
|
|
2019
|
10 |
5 |
p. 1985
|
artikel
|
| 16 |
Correction to: A Practical Guide to Delivering Nutritional Advice to People with Diabetes
|
Dyson, Pamela A.
|
|
|
10 |
5 |
p. 1985
|
artikel
|
| 17 |
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
|
Ali, Amar
|
|
2019
|
10 |
5 |
p. 1623-1624
|
artikel
|
| 18 |
Correction to: SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
|
Ali, Amar
|
|
|
10 |
5 |
p. 1623-1624
|
artikel
|
| 19 |
Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians
|
Marshall, Dominic C.
|
|
2019
|
10 |
5 |
p. 1553-1564
|
artikel
|
| 20 |
Do-It-Yourself Artificial Pancreas Systems in Type 1 Diabetes: Perspectives of Two Adult Users, a Caregiver and Three Physicians
|
Marshall, Dominic C.
|
|
|
10 |
5 |
p. 1553-1564
|
artikel
|
| 21 |
Effect of Pars Plana Vitrectomy With or Without Cataract Surgery in Patients with Diabetes: A Systematic Review and Meta-Analysis
|
Xiao, Kang
|
|
2019
|
10 |
5 |
p. 1859-1868
|
artikel
|
| 22 |
Effect of Pars Plana Vitrectomy With or Without Cataract Surgery in Patients with Diabetes: A Systematic Review and Meta-Analysis
|
Xiao, Kang
|
|
|
10 |
5 |
p. 1859-1868
|
artikel
|
| 23 |
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis
|
Yang, Lidan
|
|
2019
|
10 |
5 |
p. 1921-1934
|
artikel
|
| 24 |
Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitors in East Asians with Type 2 Diabetes: A Systematic Review and Meta-Analysis
|
Yang, Lidan
|
|
|
10 |
5 |
p. 1921-1934
|
artikel
|
| 25 |
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
|
Jude, Edward B.
|
|
2019
|
10 |
5 |
p. 1847-1858
|
artikel
|
| 26 |
Evaluating Glycemic Control in Patients with Type 2 Diabetes Suboptimally Controlled on Basal Insulin: UK ATTAIN Real-World Study
|
Jude, Edward B.
|
|
|
10 |
5 |
p. 1847-1858
|
artikel
|
| 27 |
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
|
Evans, Marc
|
|
2019
|
10 |
5 |
p. 1793-1800
|
artikel
|
| 28 |
Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin
|
Evans, Marc
|
|
|
10 |
5 |
p. 1793-1800
|
artikel
|
| 29 |
Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study
|
Liang, Xu
|
|
2019
|
10 |
5 |
p. 1801-1809
|
artikel
|
| 30 |
Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study
|
Liang, Xu
|
|
|
10 |
5 |
p. 1801-1809
|
artikel
|
| 31 |
Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group
|
Kalra, Sanjay
|
|
2019
|
10 |
5 |
p. 1577-1593
|
artikel
|
| 32 |
Glucocrinology of Modern Sulfonylureas: Clinical Evidence and Practice-Based Opinion from an International Expert Group
|
Kalra, Sanjay
|
|
|
10 |
5 |
p. 1577-1593
|
artikel
|
| 33 |
Healthcare Professionals’ Perceptions of Type 2 Diabetes Mellitus Care in the Mediterranean Region
|
Savona-Ventura, Charles
|
|
2019
|
10 |
5 |
p. 1909-1920
|
artikel
|
| 34 |
Healthcare Professionals’ Perceptions of Type 2 Diabetes Mellitus Care in the Mediterranean Region
|
Savona-Ventura, Charles
|
|
|
10 |
5 |
p. 1909-1920
|
artikel
|
| 35 |
Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?
|
Deed, Gary
|
|
2019
|
10 |
5 |
p. 1625-1643
|
artikel
|
| 36 |
Managing Cardiovascular Risk in Type 2 Diabetes: What Do the Cardiovascular Outcome Trials Mean for Australian Practice?
|
Deed, Gary
|
|
|
10 |
5 |
p. 1625-1643
|
artikel
|
| 37 |
Meta-Analysis and Cost-Effectiveness Analysis of Insulin Glargine 100 U/mL Versus Insulin Degludec for the Treatment of Type 2 Diabetes in China
|
Su, Wen
|
|
2019
|
10 |
5 |
p. 1969-1984
|
artikel
|
| 38 |
Meta-Analysis and Cost-Effectiveness Analysisof Insulin Glargine 100 U/mL Versus Insulin Degludec for the Treatment of Type 2Diabetes in China
|
Su, Wen
|
|
|
10 |
5 |
p. 1969-1984
|
artikel
|
| 39 |
Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes
|
Mita, Tomoya
|
|
2019
|
10 |
5 |
p. 1565-1575
|
artikel
|
| 40 |
Protocol of a Prospective Observational Study on the Relationship Between Glucose Fluctuation and Cardiovascular Events in Patients with Type 2 Diabetes
|
Mita, Tomoya
|
|
|
10 |
5 |
p. 1565-1575
|
artikel
|
| 41 |
Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions
|
Yang, Jincheng
|
|
2019
|
10 |
5 |
p. 1949-1957
|
artikel
|
| 42 |
Risk Factors for Doxorubicin-Induced Serious Hyperglycaemia-Related Adverse Drug Reactions
|
Yang, Jincheng
|
|
|
10 |
5 |
p. 1949-1957
|
artikel
|
| 43 |
Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Chen, Qing
|
|
2019
|
10 |
5 |
p. 1879-1892
|
artikel
|
| 44 |
Risk of Fractures Associated with Dipeptidyl Peptidase-4 Inhibitor Treatment: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
|
Chen, Qing
|
|
|
10 |
5 |
p. 1879-1892
|
artikel
|
| 45 |
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
|
Ali, Amar
|
|
2019
|
10 |
5 |
p. 1595-1622
|
artikel
|
| 46 |
SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c—Translating Evidence into Practice
|
Ali, Amar
|
|
|
10 |
5 |
p. 1595-1622
|
artikel
|
| 47 |
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes
|
Taybani, Zoltán
|
|
2019
|
10 |
5 |
p. 1869-1878
|
artikel
|
| 48 |
Simplifying Complex Insulin Regimens While Preserving Good Glycemic Control in Type 2 Diabetes
|
Taybani, Zoltán
|
|
|
10 |
5 |
p. 1869-1878
|
artikel
|
| 49 |
Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes
|
Okazaki, Kentaro
|
|
2019
|
10 |
5 |
p. 1823-1834
|
artikel
|
| 50 |
Successful Healthcare Provider Strategies to Overcome Psychological Insulin Resistance in Japanese Patients with Type 2 Diabetes
|
Okazaki, Kentaro
|
|
|
10 |
5 |
p. 1823-1834
|
artikel
|
| 51 |
The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
|
Patel, Dhiren K.
|
|
2019
|
10 |
5 |
p. 1771-1792
|
artikel
|
| 52 |
The Pleiotropic Effects of Sodium–Glucose Cotransporter-2 Inhibitors: Beyond the Glycemic Benefit
|
Patel, Dhiren K.
|
|
|
10 |
5 |
p. 1771-1792
|
artikel
|
| 53 |
Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program
|
Morillas, Carlos
|
|
2019
|
10 |
5 |
p. 1893-1907
|
artikel
|
| 54 |
Treatment of Type 2 Diabetes by Patient Profile in the Clinical Practice of Endocrinology in Spain: Delphi Study Results from the Think Twice Program
|
Morillas, Carlos
|
|
|
10 |
5 |
p. 1893-1907
|
artikel
|
| 55 |
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?
|
Evans, Marc
|
|
2019
|
10 |
5 |
p. 1719-1731
|
artikel
|
| 56 |
What Next After Metformin? Thinking Beyond Glycaemia: Are SGLT2 Inhibitors the Answer?
|
Evans, Marc
|
|
|
10 |
5 |
p. 1719-1731
|
artikel
|
Tijdschrift beschrijving